TNFRSF13C and B-cell chronic lymphocytic leukemia: The extensive expression of BAFF‐R in B‐cell malignancies, along with its crucial role in tumor cell survival, makes BAFF‐R an appealing target for CAR T‐cell therapy in CLL.33